组织芯片，组织微阵列

FDU481	宫颈癌及匹配癌旁组织组合芯片，附病理分级、TNM和临床分期，24例/48点
点数	48	例数	24
行数	6	列数	8
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:	Cer -Cervix
	AT (*) Malignant (IB1) Malignant (IIA1) Malignant (IIA2)

TISSUE ARRAYS FDU481

	1	2	3	4	5	6	7	8
A	CER	CER	CER	CER	CER	CER	CER	CER
B	CER	CER	CER	CER	CER	CER	CER	CER
C	CER	CER	CER	CER	CER	CER	CER	CER
D	CER	CER	CER	CER	CER	CER	CER	CER
E	CER	CER	CER	CER	CER	CER	CER	CER
F	CER	CER	CER	CER	CER	CER	CER	CER

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	45	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
A2	2	45	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
A3	3	31	F	Cervix	Squamous cell carcinoma (sparse)	2	T2a1N0M0	IIA1	Malignant	N
A4	4	31	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
A5	5	48	F	Cervix	Squamous cell carcinoma (CIN)	*	T1b1N0M0	IB1	Malignant	N
A6	6	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
A7	7	42	F	Cervix	Squamous cell carcinoma (without carcinoma)	*	T1b1N0M0	IB1	Malignant	N
A8	8	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
B1	9	48	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
B2	10	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
B3	11	37	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
B4	12	37	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
B5	13	41	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
B6	14	41	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
B7	15	40	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
B8	16	40	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
C1	17	71	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
C2	18	71	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
C3	19	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	N
C4	20	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
C5	21	44	F	Cervix	Squamous cell carcinoma	3	T1b1N0M0	IB1	Malignant	N
C6	22	44	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
C7	23	39	F	Cervix	Squamous cell carcinoma	3	T1b1N0M0	IB1	Malignant	N
C8	24	39	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
D1	25	32	F	Cervix	Adenocarcinoma (without epithelium)	*	T1b1N0M0	IB1	Malignant	N
D2	26	32	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
D3	27	34	F	Cervix	Adenocarcinoma	2	T2a1N0M0	IIA1	Malignant	N
D4	28	34	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
D5	29	62	F	Cervix	Adenocarcinoma	2	T1b1N0M0	IB1	Malignant	N
D6	30	62	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
D7	31	39	F	Cervix	Adenocarcinoma	3	T1b1N0M0	IB1	Malignant	N
D8	32	39	F	Cervix	Cancer adjacent cervix tissue (chronic inflammation)	*	*	*	AT	N
E1	33	48	F	Cervix	Adenocarcinoma	2	T1b1N0M0	IB1	Malignant	N
E2	34	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
E3	35	50	F	Cervix	Adenocarcinoma	2	T1b1N0M0	IB1	Malignant	N
E4	36	50	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
E5	37	42	F	Cervix	Adenocarcinoma	3	T1b1N0M0	IB1	Malignant	N
E6	38	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
E7	39	44	F	Cervix	Adenocarcinoma	2	T1b1N0M0	IB1	Malignant	N
E8	40	44	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
F1	41	51	F	Cervix	Adenocarcinoma	2	T2a2N0M0	IIA2	Malignant	N
F2	42	51	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
F3	43	50	F	Cervix	Adenocarcinoma	2	T2a2N0M0	IIA2	Malignant	N
F4	44	50	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
F5	45	56	F	Cervix	Adenocarcinoma (sparse)	*	T1b1N0M0	IB1	Malignant	N
F6	46	56	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
F7	47	47	F	Cervix	Adenocarcinoma	3	T1b1N0M0	IB1	Malignant	N
F8	48	47	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT	N
Tissue Marker